{"id":52848,"date":"2023-01-12T14:03:19","date_gmt":"2023-01-12T13:03:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/"},"modified":"2023-01-12T14:03:19","modified_gmt":"2023-01-12T13:03:19","slug":"california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/","title":{"rendered":"California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\n<i>The California Department of Healt<\/i><i>h Care Services (DHCS) selected Pear<\/i> <i>Therapeutics to track and distribute incentives for the groundbreaking Recovery Incentives: California\u2019s Contingency Management Program, to treat Medi-Cal members with stimulant use disorder<\/p>\n<p><\/i>\n<\/li>\n<li>\n<i>DHCS intends to use the pilot as a basis for informing the design and implementation of a statewide contingency management benefit through the Drug Medi-Cal Organized Delivery System, pending budgetary and statutory authority<\/i>\n<\/li>\n<\/ul>\n<p>BOSTON&#8211;(BUSINESS WIRE)&#8211;The California Department of Health Care Services (DHCS) has selected<b> <\/b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.peartherapeutics.com%2F&amp;esheet=53205445&amp;newsitemid=20230112005160&amp;lan=en-US&amp;anchor=Pear+Therapeutics%2C+Inc&amp;index=1&amp;md5=6cd557b4530f6be5ad719f25ff83be95\" rel=\"nofollow noopener\" shape=\"rect\">Pear Therapeutics, Inc<\/a>.<b> <\/b>(Nasdaq: PEAR), a leader in developing and commercializing software-based medicines, to support the implementation of the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dhcs.ca.gov%2FPages%2FDMC-ODS-Contingency-Management.aspx&amp;esheet=53205445&amp;newsitemid=20230112005160&amp;lan=en-US&amp;anchor=Recovery+Incentives%3A+California%26%238217%3Bs+Contingency+Management+Program&amp;index=2&amp;md5=34f399914e8a73c1948953c1a879dea8\" rel=\"nofollow noopener\" shape=\"rect\">Recovery Incentives: California\u2019s Contingency Management Program<\/a>. Contingency management is an evidence-based, cost-effective treatment that provides motivational incentives to treat individuals living with stimulant use disorder and support their path to recovery.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230112005160\/en\/754943\/5\/Logo-Pear-Therapeutics-Final.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230112005160\/en\/754943\/21\/Logo-Pear-Therapeutics-Final.jpg\"><\/a><\/p>\n<p>\nThe pilot program will allow eligible Medi-Cal members, across <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dhcs.ca.gov%2FPages%2FDMC-ODS-Contingency-Management.aspx&amp;esheet=53205445&amp;newsitemid=20230112005160&amp;lan=en-US&amp;anchor=24+counties+in+California&amp;index=3&amp;md5=7fff6a2d0a541b84cd435c025917594d\" rel=\"nofollow noopener\" shape=\"rect\">24 counties in California<\/a>, to take part in a structured 24-week outpatient program that will be followed by at least six months of additional recovery support services. Pear Therapeutics will partner with DHCS to deliver, implement, and manage this program, specifically by managing the electronic tracking and distribution of incentives to Medi-Cal members who participate in this contingency management pilot.\n<\/p>\n<p>\n\u201c<!-- no quote -->We applaud California\u2019s DHCS for taking this important step to expand access to behavioral treatment to address the stimulant use disorder crisis that persists in California,\u201d said Julia Strandberg, Chief Commercial Officer of Pear Therapeutics. \u201c<!-- no quote -->By working together, we will implement an innovative program that will reinforce individual positive behavioral change consistent with meeting treatment goals.\u201d\n<\/p>\n<p>\nAs stimulant use disorder continues to be pervasive across the United States, Pear Therapeutics is committed to providing individuals across the country with access to its innovative treatment options.\n<\/p>\n<p>\n<b>About Pear Therapeutics<\/b>\n<\/p>\n<p>\nPear Therapeutics, Inc. is a leader in developing and commercializing software-based medicines, called prescription digital therapeutics. Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. For more information, visit Pear at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpeartherapeutics.com&amp;esheet=53205445&amp;newsitemid=20230112005160&amp;lan=en-US&amp;anchor=www.peartherapeutics.com&amp;index=4&amp;md5=e4d68d2d3ca67f3971f83400f7b96f75\" rel=\"nofollow noopener\" shape=\"rect\">www.peartherapeutics.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media and Investors:<\/b><br \/>Meara Murphy<br \/>\n<br \/>Senior Director, Corporate Communications<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;o&#58;&#x6d;e&#97;&#x72;a&#46;&#x6d;&#117;&#x72;&#x70;&#104;&#x79;&#x40;&#112;&#x65;a&#114;&#x74;h&#101;&#x72;a&#112;&#x65;u&#116;&#x69;&#99;&#x73;&#x2e;&#99;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">meara&#46;murphy&#64;&#112;&#101;&#97;&#114;&#116;&#104;&#101;&#114;&#97;&#112;&#101;&#117;&#116;&#105;&#x63;&#x73;&#x2e;&#x63;&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The California Department of Health Care Services (DHCS) selected Pear Therapeutics to track and distribute incentives for the groundbreaking Recovery Incentives: California\u2019s Contingency Management Program, to treat Medi-Cal members with stimulant use disorder DHCS intends to use the pilot as a basis for informing the design and implementation of a statewide contingency management benefit through &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52848","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The California Department of Health Care Services (DHCS) selected Pear Therapeutics to track and distribute incentives for the groundbreaking Recovery Incentives: California\u2019s Contingency Management Program, to treat Medi-Cal members with stimulant use disorder DHCS intends to use the pilot as a basis for informing the design and implementation of a statewide contingency management benefit through ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-12T13:03:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230112005160\/en\/754943\/21\/Logo-Pear-Therapeutics-Final.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program\",\"datePublished\":\"2023-01-12T13:03:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\\\/\"},\"wordCount\":377,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230112005160\\\/en\\\/754943\\\/21\\\/Logo-Pear-Therapeutics-Final.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\\\/\",\"name\":\"California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230112005160\\\/en\\\/754943\\\/21\\\/Logo-Pear-Therapeutics-Final.jpg\",\"datePublished\":\"2023-01-12T13:03:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230112005160\\\/en\\\/754943\\\/21\\\/Logo-Pear-Therapeutics-Final.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230112005160\\\/en\\\/754943\\\/21\\\/Logo-Pear-Therapeutics-Final.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/","og_locale":"en_US","og_type":"article","og_title":"California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program - Pharma Trend","og_description":"The California Department of Health Care Services (DHCS) selected Pear Therapeutics to track and distribute incentives for the groundbreaking Recovery Incentives: California\u2019s Contingency Management Program, to treat Medi-Cal members with stimulant use disorder DHCS intends to use the pilot as a basis for informing the design and implementation of a statewide contingency management benefit through ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-12T13:03:19+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230112005160\/en\/754943\/21\/Logo-Pear-Therapeutics-Final.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program","datePublished":"2023-01-12T13:03:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/"},"wordCount":377,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230112005160\/en\/754943\/21\/Logo-Pear-Therapeutics-Final.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/","url":"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/","name":"California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230112005160\/en\/754943\/21\/Logo-Pear-Therapeutics-Final.jpg","datePublished":"2023-01-12T13:03:19+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230112005160\/en\/754943\/21\/Logo-Pear-Therapeutics-Final.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230112005160\/en\/754943\/21\/Logo-Pear-Therapeutics-Final.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/california-department-of-health-care-services-awards-contract-to-pear-therapeutics-to-support-the-recovery-incentives-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52848"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52848\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52848"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52848"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}